The Diagnosis and Treatment of Multiple Myeloma

about

Monoclonal IgM Gammopathy and Waldenström's Macroglobulinemia.Anaesthesia for fixation of repeated pathological fractures in a patient with multiple myeloma.Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma

P2860

Q47134329-4011716C-6FC0-4BB2-A870-11AAADC6B85B Q47214775-E5854A51-3ABA-4CD9-98E6-43C866D8F068 Q49649026-BB637385-031C-4A0F-9663-542C4352201C

P2860

The Diagnosis and Treatment of Multiple Myeloma

Item

http://www.wikidata.org/entity/Q37150733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Diagnosis and Treatment of Multiple Myeloma

@en

The Diagnosis and Treatment of Multiple Myeloma.

@nl

type

Item

label

The Diagnosis and Treatment of Multiple Myeloma

@en

The Diagnosis and Treatment of Multiple Myeloma.

@nl

prefLabel

The Diagnosis and Treatment of Multiple Myeloma

@en

The Diagnosis and Treatment of Multiple Myeloma.

@nl

P1476

The Diagnosis and Treatment of Multiple Myeloma

@en

P2093

Christian Gerecke

http://www.w3.org/2001/XMLSchema#string

Martin Schmidt-Hieber

http://www.w3.org/2001/XMLSchema#string

Stefan Knop

http://www.w3.org/2001/XMLSchema#string

Stephan Fuhrmann

http://www.w3.org/2001/XMLSchema#string

Susanne Strifler

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonates in multiple myeloma: a network meta-analysis

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Smoldering multiple myeloma.

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Venous thromboembolism in multiple myeloma.

Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.

P304

470-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2016.0470

http://www.w3.org/2001/XMLSchema#string

P433

27-28

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Hermann Einsele

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27476706

http://www.w3.org/2001/XMLSchema#string

P932

4973001

http://www.w3.org/2001/XMLSchema#string

The Diagnosis and Treatment of Multiple Myeloma

about

P2860

P2860

The Diagnosis and Treatment of Multiple Myeloma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932